November 10, 2025 · Form 4 insider transaction
Cross Shawn sold 12,060 shares of Pacira BioSciences, Inc. at $22.09 per share, a transaction worth $266.4K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 3 days after the transaction.
The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.